Clinical Trial Update: Efficacy and Safety of Insulin Aspart in Subjects With Type 1 or Type 2 Diabetes [Phase 4]

View source ↗

Summary

Phase 4 trial evaluates the efficacy and safety of insulin aspart in subjects with type 1 or type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• Insulin aspart (insulin aspart)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Phase 4 | Status: COMPLETED